ロード中...

Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis

BACKGROUND: A number of elements of the pivotal ‘cladribine tablets treating multiple sclerosis orally’ (CLARITY) trial have remained unpublished. OBJECTIVE: To report the impact of cladribine on health-related quality of life (QoL) in people with relapsing multiple sclerosis (pwRMS). METHODS: QoL d...

詳細記述

保存先:
書誌詳細
出版年:Mult Scler
主要な著者: Afolabi, Dayo, Albor, Christo, Zalewski, Lukasz, Altmann, Dan R, Baker, David, Schmierer, Klaus
フォーマット: Artigo
言語:Inglês
出版事項: SAGE Publications 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6174629/
https://ncbi.nlm.nih.gov/pubmed/28817997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517726380
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!